ResMed Adopts New Operating Model to Accelerate Long-term …
WEBSAN DIEGO, November 9, 2023 – ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated leadership in Product, Revenue, and Marketing to the global executive team.
ResMed: Growing Returns With Continuous Acquisitions Led To A …
WEB20 hours ago · ResMed achieved double-digit revenue growth through acquisitions and operating efficiencies, with improving capital efficiencies and strong profitability. See more.
ResMed Faces Market Disruption and Limited Growth: A Sell …
WEB2 days ago · ResMed Faces Market Disruption and Limited Growth: A Sell Rating Analysis. Wolfe Research analyst Michael Polark downgraded the rating on Resmed (RMD – Research Report) to a Sell yesterday ...
ResMed Inc. Announces Results for the Second Quarter of Fiscal …
WEBDec 31, 2023 · SAN DIEGO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2023. Second Quarter 2024 Highlights. All comparisons are to the prior year period. Revenue increased by 12% to $1.2 billion; up 11% on a constant currency basis.
Why ResMed's Rally Is Just Getting Started - Seeking Alpha
WEB1 day ago · ResMed's AirSense 11 platform and myAir app enhance patient engagement and efficiency. Check out why I remain bullish on RMD stock.
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal …
WEBSAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2024. Fourth Quarter 2024 Highlights. All comparisons are to the prior year period. Revenue increased by 9% to $1.2 billion; up 10% on a constant currency basis.
Study Estimates a 23% Increase in COPD by 2050 ... - ResMed …
WEBSAN DIEGO, December 7, 2023 – ResMed (NYSE: RMD, ASX: RMD) today announced the results of a study on the global burden of Chronic Obstructive Pulmonary Disease (COPD) through 2050. Published in the Journal of the American Medical Association (JAMA) Network Open, the study found that COPD prevalence among those 25 years and older is expected ...
Resmed Stock Poised for Growth: Buy Rating Affirmed Amid …
WEBApr 17, 2024 · In a report released today, Lyanne Harrison from Bank of America Securities reiterated a Buy rating on Resmed (RMD – Research Report), with a price target of $220.00.
ResMed Inc. Announces Results for the Second Quarter of Fiscal …
WEBSAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2022. Second Quarter 2023 Highlights. All comparisons are...
FDA Issues New Recall Alert For ResMed CPAP Devices: Here's …
WEBJun 3, 2024 · ResMed is recalling these masks to update the labels, add more warnings and information to guide patients and health care professionals on safe usage when using masks with magnets.” This isn’t the first company to have a recall for this type of concern with magnets in CPAP masks.
Skip to content